Table 6.
Key | Dataset(s) origin | Dataset(s) type | Dataset(s) length | Scope | Approach | Clustering feature(s) | Number of clusters found |
---|---|---|---|---|---|---|---|
Visser et al., 2007 | Dutch university hospitals |
Real-life | 37 | Progression | Clinical observations | Limb involvement | 3 |
Gomeni and Fava, 2013 | ProACT | Clinical trial | 338 | Progression | Unsupervised (non-linear Weibull model rajiestimation) |
Clinical features | 2 |
Balendra et al., 2014a | LiCALS, Mito Target |
Clinical trial | 725 | Progression | Clinical observations | Clinical stages | 5 |
Ko et al., 2014 | ProAct | Clinical trial | 1822 | Progression | Clinical observations | ALSFRS decline rate |
2 |
Elamin et al., 2015 | Irish ALS registry, Italy (Piemonte Region) |
Population | 326 | Outcome | Clinical observations | Score based on onset type, ALSFRS rate an executive disfunction |
3 |
Marin et al., 2015 | FRALim register | Population | 322 | Outcome | Unsupervised (RECPAM) | Clinical features | 4 |
RECPAM, Recursive Partitioning and Amalgation.